Masha Stromme
Mentor at Nordic Mentor Network For Entrepreneurship - NOME- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Nordic Mentor Network For Entrepreneurship - NOME
-
Denmark
-
Business Consulting and Services
-
1 - 100 Employee
-
Mentor
-
Jun 2018 - Present
-
-
-
European Innovation Council and SMEs Executive Agency (EISMEA)
-
Belgium
-
Government Administration
-
200 - 300 Employee
-
Jury Member
-
Jun 2021 - Present
-
-
-
GenieUs Genomics
-
Australia
-
Biotechnology
-
1 - 100 Employee
-
Member of the Board
-
Aug 2021 - Present
-
-
-
Hemispherians AS
-
Oslo, Norway
-
Member of the Board of Directors
-
Jan 2021 - Present
-
-
-
PAACS Invest AS
-
Oslo, Norway
-
Co-Chair PAACS Invest
-
Sep 2015 - Present
-
-
-
Exact Therapeutics AS
-
Oslo Area, Norway
-
Vice Chair of the Board of Directors
-
Jun 2018 - Present
-
-
-
PubGene Inc
-
Oslo Area, Norway
-
Member of the Board of Directors
-
Mar 2019 - Present
-
-
-
-
Partner
-
Sep 2012 - Present
Advise and invest in healthcare companies. Current focus on medical technology and elderly care Advise and invest in healthcare companies. Current focus on medical technology and elderly care
-
-
-
Norway Health Tech
-
Norway
-
Non-profit Organizations
-
1 - 100 Employee
-
Advisor
-
May 2014 - Dec 2020
-
-
-
-
Member Board of Directors
-
Jun 2015 - Jun 2018
First external investor in Phoenix Solutions AS, a Norwegian biotech company spun out from GE Healthcare in 2013, currently developing a technology platform for targeted drug delivery – Acoustic Cluster Therapy (ACT®). ACT® is a unique approach to ultrasound (US) mediated, targeted drug delivery – capable of enhancing significantly the clinical utility of a wide range of therapeutic molecules and nano-drugs for a wide range of clinical indications. ACT®`s primary mode of action is in defeating the vascular barrier and enhancing extravasation for greater distribution and uptake of a co-administered drug to the targeted tissue, with resulting increased efficacy and/or reduction in toxicity.
-
-
-
Biotec Pharmacon ASA
-
Norway
-
Biotechnology Research
-
1 - 100 Employee
-
Member Board of Directors
-
Jun 2015 - May 2018
-
-
-
Arctic Securities
-
Investment Banking
-
100 - 200 Employee
-
Advisor to the Healthcare Team
-
Jan 2015 - Apr 2018
-
-
-
Navamedic ASA
-
Norway
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Member Board of Directors
-
Jan 2008 - Oct 2016
-
-
Education
-
University of Oxford
D.Phil, Biochemistry, genetics and neuroscience -
McGill University
Bachelor of Science (BSc), Biology, General